支气管内膜结核的介入治疗33例报告

目的：探讨介入治疗对支气管内膜结核患的治疗价值。方法：支气管内膜结核患在全身化疗的基础上，对33例行纤支镜下介入治疗，病变部位注入含异烟肼，利福平，吡嗪酰胺的抗痨凝胶，每2－3周1次，另36例雾化吸入异烟肼和链霉素的患作为对照组，结果：治疗组中痰结核菌阳性患的阴转率（92．0％）高于对照组（52．2％），阴转时间短于对照组，介入治疗对支气管内膜结核溃疡坏死型和肉芽增殖型肺不张的疗效好于对照组，而对疤痕狭窄型的肺不张无效，结论：介入治疗治疗支气管内膜结核疗效可靠，安全性好。

Catheter intervention in the treatment of endomembrane pulmonary tuberculosis

Objective To explore the effects of catheter intervention in the treatment of endomembrane plumonar tuberculosis.Method Based on general chemotherapy, 33 patients with endomembrane tuberculosis underwent intervention therapy by bronchoscope, in which isoniazide, rifampin and pyrazinamide gel were injected on the part of lesion every 2 to 3 weeks. Another group with 36 cases using pulverized isoniazide and streptomycin was regarded as controls.Results The test group achieved higher negative bacteriology transform rate (92%) than the controls (52.2%) and the former had shorter time in achieving the results. The method was better in treating endomembrane tuberculosis with lung atrophy due to ulcerous necrosis or granulation, but ineffective in atrophy due to fibrous constriction. Conclusion Catheter intervention is a reliable and safe method in the treatment of endomembrane pulmonary tuberculosis.